Hiraki M, Arichi N, Kishi H, Yasumoto H, Shiina H: Unexpected activation of type I interferon signaling pathway after zoledronic acid treatment in prostate cancer cell-its significance in cancer progression. 16thUrological Association of Asia Congress 2018(UAA) 京都市. 2018年4月
Sumura H,Yamasaki T, Nagami T, Nakanishi Y, Inoue K, Arichi N, Kishi H, Yasumoto H, Shiina H:High-resolution 3D Magnetic Resonance Spectroscopic Imaging Without Endorectal Surface Coil Clearly Illustrates Prostate Cancer using Novel Imaging Sequence. AUA 2018(American Urological Association) Annual Meeting,san francisco,USA May 18-22,2018
Arichi N:what is Your Choice of Treatment?(Panel Discussion on Clinical Cases). AUA 2018(American Urological Association) Annual Meeting,san francisco,USA May 18-22,2018
Shiina H:Alteration of androgen-targeted therapy in men with advanced prostate cancer.The 35th KOREA-JAPAN Urological Congress,Okinawa,December 2018
椎名浩昭:転移性去勢抵抗性前立腺癌の治療~Bone health を考慮した治療戦略を考える~What should we do against metastatic CRPC? -based upon the knowledge coming from recent update on bone health-.日本泌尿器腫瘍学会第4回学術集会.横浜市,2018年10月
福島貴郁, 平木美穂, 杉谷智之, 有地直子, 安本博晃, 椎名浩昭:Gene alteration involved in the senescent state affecting the cellular components of normal prostate and its biological role in the prostate cancer cell.第70回西日本泌尿器科学会総会.長崎市,2018年11月
Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.:Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy. J Urol. 2018 Apr;199(4):933-939
Miyake M, Tatsumi Y, Matsumoto H, Nagao K, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H, Fujimoto K; Nishinihon Uro-Oncology Collaborative Group.:Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma. BJU Int. 2018 May;121(5):764-773.
Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.:Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study. Int J Urol. 2018 May;25(5):500